[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
April 11, 2001

Results of CURE Trial for Acute Coronary Syndrome

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;285(14):1828-1829. doi:10.1001/jama.285.14.1828-JMN0411-2-1

Orlando, Fla—Clopidogrel, an antiplatelet medication, was found when taken daily with aspirin to reduce risk of cardiovascular death, myocardial infarction (MI), and stroke by almost 20% in patients with acute coronary syndrome. Researchers said the drug, if given to everyone in the United States with acute coronary syndrome, could prevent between 50 000 and 100 000 new MIs, strokes, and deaths annually. The findings, by a research team headed by Salim Yusuf, MD, professor of medicine and director of the Division of Cardiology at McMaster University in Hamilton, Ontario, were presented at this year's American College of Cardiology Scientific Sessions.

First Page Preview View Large
First page PDF preview
First page PDF preview
×